Our current research
This page includes some research opportunities which you may be interested in.
Please be aware that:
- This is only a small selection of our research studies. You can find more research opportunities at the Be Part of Research and Join Dementia Research websites. If a study is not immediately available, you can ask to be contacted about future opportunities. Also feel free to get in touch with us
- Each research study has ‘eligibility criteria’ for who can and cannot take part. We can explain this further if you would like to get in touch with us
- We have a separate guidance page if, instead of being a study participant, you would like to be involved in other ways
Research opportunities
If you would like further information about any research opportunities, please email us: [email protected].
COmBining memantine And cholinesterase inhibitors in Lewy body dementia Treatment trial (COBALT)
In conjunction with Newcastle University, the Cobalt trial will look at the use of a drug called memantine, for treatment of people with Dementia with Lewy Bodies (DLB) and Parkinson’s Disease Dementia (PDD) symptoms.
The aim of the COBALT trial is to find out if Memantine treatment can help improve overall health and functioning for people with DLB or PDD.
Potential participants should be currently taking cholinesterase inhibitors.
Improving diabetes self-management for people with severe mental illness (DIAMONDS)
The DIAMONDS study looks at a new support programme to help people with Type-2 Diabetes and a severe mental illness to manage their diabetes.
You may be able to take part if you:
- Be aged 18 or over
- Have a diagnosis of Schizophrenia, Bipolar Disorder, Schizoaffective Disorder, Psychosis or Severe Depression
- Have a diagnosis of Type 2 Diabetes
Community-based Behavioural Activation Training for Depression in Adolescents (COMBAT)
ComBAT is a research programme to develop, implement and evaluate Behavioural Activation (BA).
Behavioural Activation is a psychological therapy for young people aged 12-18 years with mild to moderate depression.
Stimulant Medication for ADHD and Tics – Understanding Response versus Non-stimulants (SATURN)
The SATURN trial wants to find out which one of two medications is the best treatment for children and young people with both ADHD and tics.
You may be able to take part if you:
- Are aged between 6 and 16
- Have a diagnosis of ADHD but also experience tics
- Not be currently taking medication for their ADHD or looking to change medication
A parent or carer would also be asked to enrol alongside the child or young person to help them engage with and complete the study activities.
Genetic Links to Anxiety and Depression (GLAD)
Depression and anxiety are the most common mental health disorders worldwide. In the UK, one in three people will experience symptoms during their lifetime. The GLAD Study aims to better understand depression and anxiety in order to find effective treatments and improve the lives of people experiencing these disorders.
You may be able to take part if you:
- Have experienced depression and/or anxiety during your life
- Be aged 16 and above
- Live in the UK
Find more research opportunities
Be Part of Research makes it easy to find and take part in vital health and care research across the UK.
Research outcomes
Through the sleep intervention effectiveness study tailored for adult (SIESTA) inpatients research project, we talked to 102 inpatients at Ridgeway, Roseberry Park Hospital. We wanted to know what sleep is like for people staying in hospital.
Following this, there were seven focus groups with patients, staff and carers. There was a wide range of views about patients’ sleep, the causes of poor sleep, the consequences of poor sleep and how things could be improved.
We’re now using what we’ve learnt to create new ways of helping patients to sleep better.
